iShares NASDAQ Biotechnology Index (IBB) Receives Consensus Rating of "" from Analysts – The Cerbat Gem


BBNS
iShares NASDAQ Biotechnology Index (IBB) Receives Consensus Rating of "" from Analysts
The Cerbat Gem
iShares NASDAQ Biotechnology Index logo Shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) have been given an average broker rating score of 0.00 () from the zero analysts that provide coverage for the company, Zacks Investment Research ...
Courier Capital LLC Continues to Hold Stake in iShares NASDAQ Biotechnology Index (IBB)BBNS
iShares NASDAQ Biotechnology Index (IBB) Upgraded by Vetr Inc. to BuyTranscript Daily
Vetr Inc. Upgrades iShares NASDAQ Biotechnology Index (IBB) to "Buy"Sports Perspectives
Breaking Finance News
all 9 news articles »

See the original post here:
iShares NASDAQ Biotechnology Index (IBB) Receives Consensus Rating of "" from Analysts - The Cerbat Gem

Related Posts

Comments are closed.